BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Nele Brusselaers, Jesper Lagergren, Lars Engstrand. Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancerCancer Epidemiology 2019; 62: 101585 doi: 10.1016/j.canep.2019.101585
2
Nele Brusselaers, Omid Sadr-Azodi, Lars Engstrand. Long-term proton pump inhibitor usage and the association with pancreatic cancer in SwedenJournal of Gastroenterology 2019;  doi: 10.1007/s00535-019-01652-z
3
Enrico Pierluigi Spugnini, Stefano Fais. Drug repurposing for anticancer therapies. A lesson from proton pump inhibitorsExpert Opinion on Therapeutic Patents 2020; 30(1): 15 doi: 10.1080/13543776.2020.1704733
4
Andrea Nuzzo, James R. Brown. The Microbiome Factor in Drug Discovery and DevelopmentChemical Research in Toxicology 2020; 33(1): 119 doi: 10.1021/acs.chemrestox.9b00333